Terminology Service < Semantic Lookup Platform

All terms in GO

Label	Id	Description
regulation of type IIb hypersensitivity	GO_0001799	[Any process that modulates the frequency, rate, or extent of type IIb hypersensitivity, a type of inflammatory response.]
regulation of type II hypersensitivity	GO_0002892	[Any process that modulates the frequency, rate, or extent of type II hypersensitivity.]
type IIb hypersensitivity	GO_0001795	[An inflammatory response resulting in cell death or dysfunction mediated by the direct binding of antibody to cellular receptors.]
negative regulation of type IIa hypersensitivity	GO_0001797	[Any process that stops, prevents, or reduces the rate of type IIa hypersensitivity, a type of inflammatory response.]
negative regulation of type II hypersensitivity	GO_0002893	[Any process that stops, prevents, or reduces the frequency, rate, or extent of type II hypersensitivity.]
type II hypersensitivity	GO_0002445	[An inflammatory response resulting in cell death or dysfunction mediated by activation of the classical complement pathway or induction of effector cell phagocytosis, cytolysis mechanisms via complement or Fc receptors following the binding of antibodies to cell surface antigens on a target cell, or mediated by the direct binding of antibody to cellular receptors.]
polymeric immunoglobulin receptor activity	GO_0001792	[Combining with a J-chain-containing polymeric immunoglobulin of the IgA or IgM isotypes via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.]
polymeric immunoglobulin binding	GO_0001790	[Interacting selectively and non-covalently with a J-chain-containing polymeric immunoglobulin of the IgA or IgM isotypes.]
IgM receptor activity	GO_0001793	[Combining with an immunoglobulin of the IgM isotype via the Fc region, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.]
IgM binding	GO_0001791	[Interacting selectively and non-covalently with an immunoglobulin of the IgM isotype.]
regulation of interleukin-1 alpha biosynthetic process	GO_0050721	[Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-1 alpha.]
regulation of interleukin-1 alpha production	GO_0032650	[Any process that modulates the frequency, rate, or extent of interleukin-1 alpha production.]
interleukin-1 alpha biosynthetic process	GO_0050719	[The chemical reactions and pathways resulting in the formation of interleukin-1 alpha.]
regulation of interleukin-1 beta biosynthetic process	GO_0050722	[Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-1 beta.]
regulation of interleukin-1 beta production	GO_0032651	[Any process that modulates the frequency, rate, or extent of interleukin-1 beta production.]
interleukin-1 beta biosynthetic process	GO_0050720	[The chemical reactions and pathways resulting in the formation of interleukin-1 beta.]
negative regulation of interleukin-1 alpha biosynthetic process	GO_0050723	[Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-1 alpha.]
negative regulation of interleukin-1 alpha production	GO_0032690	[Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 alpha production.]
negative regulation of interleukin-1 beta biosynthetic process	GO_0050724	[Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-1 beta.]
negative regulation of interleukin-1 beta production	GO_0032691	[Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 beta production.]